135306-85-3

MEN 10376 MEN-10,376 ≥95% MEN-10,376, ≥95% (HPLC) MEN-10,376 , ≥95% (HPLC) M.W. 1081.24 C57H68N12O10 Neurokinin-2 receptor antagonist ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2 H-ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2 tyr(5)-trp(6,8,9)-lys(10)-neurokinina(4-10 [TYR5, D-TRP6,8,9, LYS10]NEUROKININ A (4-10) L-Asp-L-Tyr-D-Trp-L-Val-D-Trp-D-Trp-L-Lys-NH2 neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)- (Tyr5,D-Trp6.8.9,Lys-NH21?)-Neurokinin A (4-10) MEN-10,376 SYNTHETIC >95% NK2 TACHYKININ RECEPT (tyr5,D-trp6,8,9,lys10)-A-neurokinin*fragment 4-1 (TYR5,D-TRP6,8,9,LYS-NH(2/10))-NEUROKININ A (4-10) [TYR5,D-TRP6,8 9,LYS10]-ALPHA-NEUROKININ A FRAGMENT 4-10 alpha-neurokinin, fragment 4-10, [Tyr5, Trp6,8,9, Lys10] (Tyr5,D-Trp6·8·9,Lys-NH210)-Neurokinin A (4-10) MEN 10376 [TYR5 ,D -TRP6,8 9 ,LYS10 ]-ALPHA-NEUROKININ A FRAGMENT 4-10 97% L-Lysinamide, L-a-aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl- L-Lysinamide, L-α-aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl- L-alpha-Aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-L-lysinamide 3-amino-4-[[1-[[1-[[1-[[1-[[1-[(1,6-diamino-1-oxohexan-2-yl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropa 3-amino-4-[[1-[[1-[[1-[[1-[[1-[(1,6-diamino-1-oxohexan-2-yl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid